Cubist Systematic Strategies’s HOOKIPA Pharma HOOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,011
Closed -$14K 4391
2022
Q3
$14K Buy
+1,011
New +$15.5K ﹤0.01% 4264
2022
Q2
Sell
-724
Closed -$17K 4431
2022
Q1
$17K Sell
724
-905
-56% -$16.2K ﹤0.01% 3482
2021
Q4
$38K Sell
1,629
-930
-36% -$37.4K ﹤0.01% 3337
2021
Q3
$151K Buy
2,559
+197
+8% +$14.3K ﹤0.01% 2657
2021
Q2
$216K Buy
+2,362
New +$315K ﹤0.01% 2511

Other funds holding HOOK

Cubist Systematic Strategies's HOOK Position: Q4 2022 in Review

Cubist Systematic Strategies sold out of HOOKIPA Pharma (HOOK) in Q4 2022, closing a stake of 1,011 shares — an estimated $14K sold.

Cubist Systematic Strategies first reported a position in HOOK in Q2 2021 and held it in 5 quarters. The position peaked at $216K in Q2 2021. 55 funds tracked by Wall St. Rank hold HOOK as of Q4 2022.

  • Cubist Systematic Strategies reported no remaining HOOKIPA Pharma position as of Q4 2022 after selling out during the quarter.
  • Cubist Systematic Strategies sold 1,011 HOOKIPA Pharma shares in Q4 2022, an estimated $14K.
  • Cubist Systematic Strategies first reported a position in HOOKIPA Pharma in Q2 2021 and held it in 5 quarters.
  • Cubist Systematic Strategies's HOOKIPA Pharma position peaked at $216K in Q2 2021.
  • 55 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q4 2022.

Based on Cubist Systematic Strategies's 13F filing for Q4 2022, filed 14 Feb 2023.